Welcome to ARE Labs, where innovation meets accuracy in our state-of-the-art inhalation test services. As pioneers in the field, we specialize in the detailed examination of aerosol drug delivery systems and respiratory devices, ensuring they deliver on efficacy, safety, and dosage precision. Our suite of services is designed to rigorously evaluate a range of inhalation therapies, from nebulizers and metered-dose inhalers to dry powder inhalers, making us a trusted partner in pharmaceutical development.
Comprehensive Analysis: With expertise in advanced testing methodologies like cascade impaction, laser diffraction particle sizing, and simulated breathing models, we offer an unparalleled depth of analysis.
Particle Size Distribution: Precise assessments to ensure optimal aerosol delivery and therapeutic effectiveness.
Dosage Accuracy: Verification of delivered doses to align with intended therapeutic outcomes.
Aerodynamic Characteristics: Evaluation of aerosol behavior and performance within respiratory tracts.
In-Vitro Inhalation Exposure Studies:
Utilizing simulated human breathing models, we conduct in-vitro inhalation exposure studies for pharmaceuticals and consumer products, ensuring real-world relevance and reliability.
Rodent Inhalation Studies:
Ethical and scientifically rigorous inhalation studies on rodents, supporting OECD toxicity evaluations, inhalation dose modeling, and in-vitro exposure assessments.
Environmental Inhalation Risk Assessments:
Employing advanced Computational Fluid Dynamics (CFD) modeling to analyze inhalation risks in various commercial and industrial settings, aiding in the creation of safer environments.
At ARE Labs, our dedication to supporting pharmaceutical innovation is matched by our commitment to meeting stringent clinical and regulatory standards. Our inhalation test services are integral to the development process, ensuring products not only achieve but exceed the necessary benchmarks for therapeutic efficacy and patient safety.